32695253|t|Metformin Protects ARPE-19 Cells from Glyoxal-Induced Oxidative Stress.
32695253|a|The protective effects and mechanisms of metformin against oxidative stress were evaluated both in vivo and in vitro. ARPE-19 cells comprised the normal group, the glyoxal-treated group (0.5 mM glyoxal), and the glyoxal+metformin group (0.5 mM glyoxal and 0.1 mM metformin). In the in vitro model, differences in cell viability, ROS production, NO products, cellular apoptosis, and the expressions of phospho-AMPKalpha, total-AMPKalpha, Sirt1, Nrf2, TXNIP, ZO-1, and Occludin were assessed. In the glyoxal-treated group, cell viability and NO production were decreased, while ROS production and cell apoptosis were increased (p < 0.05), compared with the control group. These changes were prevented by metformin treatment. Protein expressions of phospho-AMPKalpha, Sirt1, TXNIP, ZO-1, and Occludin, but not Nrf2, were decreased significantly in the glyoxal-treated group compared to normal controls. Metformin treatment significantly increased the above protein expressions and slightly increased TXNIP expression. Immunofluorescence showed that metformin prevented the glyoxal-induced, disorganized tight junctions in ARPE-19 cells. To confirm metformin's protection, Sprague-Dawley rats were injected intravenously with sodium iodate (SI) to induce oxidative stress in the retinal pigment epithelium (RPE). Metformin was then delivered intraperitoneally or intravitreally. One day and three days after SI and metformin treatments, the RPE-Bruch's membrane-choriocapillaris complex was isolated and immune-stained with ZO-1 antibodies. The morphology of the RPE showed enlarged cellular bodies and disorganized ZO-1 staining in SI-treated rats. Metformin treatment prevented these changes. The results indicated that metformin maintained the barrier functions of RPE cells both in vivo and in vitro. Metformin exerted its protection against oxidative stress possibly via activating AMPK/Sirt1 and increasing TXNIP. Metformin has been proposed as a candidate drug for age-related macular degeneration (AMD) by both preclinical and clinical studies. The cellular and animal models used in this study might be useful for the interpretation of the molecular mechanisms involved in the drug activity.
32695253	0	9	Metformin	Chemical	MESH:D008687
32695253	19	26	ARPE-19	CellLine	CVCL:0145
32695253	38	45	Glyoxal	Chemical	MESH:D006037
32695253	113	122	metformin	Chemical	MESH:D008687
32695253	190	197	ARPE-19	CellLine	CVCL:0145
32695253	236	243	glyoxal	Chemical	MESH:D006037
32695253	266	273	glyoxal	Chemical	MESH:D006037
32695253	284	291	glyoxal	Chemical	MESH:D006037
32695253	292	301	metformin	Chemical	MESH:D008687
32695253	316	323	glyoxal	Chemical	MESH:D006037
32695253	335	344	metformin	Chemical	MESH:D008687
32695253	401	404	ROS	Chemical	-
32695253	509	514	Sirt1	Gene	23411
32695253	516	520	Nrf2	Gene	4780
32695253	522	527	TXNIP	Gene	10628
32695253	529	533	ZO-1	Gene	7082
32695253	539	547	Occludin	Gene	100506658
32695253	570	577	glyoxal	Chemical	MESH:D006037
32695253	648	651	ROS	Chemical	-
32695253	774	783	metformin	Chemical	MESH:D008687
32695253	837	842	Sirt1	Gene	23411
32695253	844	849	TXNIP	Gene	10628
32695253	851	855	ZO-1	Gene	7082
32695253	861	869	Occludin	Gene	100506658
32695253	879	883	Nrf2	Gene	4780
32695253	921	928	glyoxal	Chemical	MESH:D006037
32695253	972	981	Metformin	Chemical	MESH:D008687
32695253	1069	1074	TXNIP	Gene	10628
32695253	1118	1127	metformin	Chemical	MESH:D008687
32695253	1142	1149	glyoxal	Chemical	MESH:D006037
32695253	1191	1198	ARPE-19	CellLine	CVCL:0145
32695253	1217	1226	metformin	Chemical	MESH:D008687
32695253	1256	1260	rats	Species	10116
32695253	1294	1307	sodium iodate	Chemical	MESH:C032285
32695253	1309	1311	SI	Chemical	MESH:C032285
32695253	1347	1362	retinal pigment	CellLine	CVCL:IQ82
32695253	1375	1378	RPE	CellLine	CVCL:IQ82
32695253	1381	1390	Metformin	Chemical	MESH:D008687
32695253	1476	1478	SI	Chemical	MESH:C032285
32695253	1483	1492	metformin	Chemical	MESH:D008687
32695253	1509	1512	RPE	CellLine	CVCL:IQ82
32695253	1592	1596	ZO-1	Gene	292994
32695253	1631	1634	RPE	CellLine	CVCL:IQ82
32695253	1684	1688	ZO-1	Gene	7082
32695253	1701	1703	SI	Chemical	MESH:C032285
32695253	1712	1716	rats	Species	10116
32695253	1718	1727	Metformin	Chemical	MESH:D008687
32695253	1790	1799	metformin	Chemical	MESH:D008687
32695253	1836	1839	RPE	CellLine	CVCL:IQ82
32695253	1873	1882	Metformin	Chemical	MESH:D008687
32695253	1955	1959	AMPK	Gene	5563
32695253	1960	1965	Sirt1	Gene	23411
32695253	1981	1986	TXNIP	Gene	10628
32695253	1988	1997	Metformin	Chemical	MESH:D008687
32695253	2040	2072	age-related macular degeneration	Disease	MESH:D008268
32695253	2074	2077	AMD	Disease	MESH:D008268
32695253	Positive_Correlation	MESH:D008687	10628
32695253	Negative_Correlation	MESH:D006037	100506658
32695253	Negative_Correlation	MESH:D006037	MESH:D008687
32695253	Negative_Correlation	MESH:D006037	10628
32695253	Positive_Correlation	MESH:D008687	100506658
32695253	Negative_Correlation	MESH:D006037	7082
32695253	Positive_Correlation	MESH:D008687	7082
32695253	Negative_Correlation	MESH:D006037	23411
32695253	Positive_Correlation	MESH:D008687	23411
32695253	Negative_Correlation	MESH:D006037	4780

